Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRESERVE trial
2006-003483-59Phase 4Completed
- Sponsor
- VU University Medical Centre
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of rosiglitazone and valsartan in prediabetes and impaired fasting glucose (IFG) (4 arms), sponsored by VU University Medical Centre. Primary endpoints: First-phase insulin secretion corrected for insulin sensitivity and Arginine-stimulated insulin secretion. Started Dec 2007; status: completed.
02
Drugs
rosiglitazonevalsartan
03
Conditions
prediabetesimpaired fasting glucose (IFG)
Beyond the preview
Go deeper on 2006-003483-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003483-59.